Clinical trial

European Registry of Next Generation Imaging in Advanced Prostate Cancer

NCT06866782

Study summary

ClinicalTrials.gov

European Registry of Next Generation Imaging in Advanced Prostate Cancer

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention Imaging Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-09-17

PhaseN/A

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Advanced Prostate Cancerunresolved

Metastatic Prostate Cancer (mPC)unresolved

Interventions

ImagingDIAGNOSTIC_TEST

Sponsors & collaborators

Fundacio Puigvertlead sponsor

European Association of Urology Research Foundationcollaborator

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARDcollaborator

European Association of Urology - Section of Urological Imagingcollaborator

Johnson & Johnsoncollaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Paucollaborator

Mapped research locations

MadridSpain2 BarcelonaSpain2 FlorenceItaly2 ParisFrance1 MilanItaly1 HamburgGermany1 LyonFrance1 LilleFrance1 LeuvenBelgium1 KrakowPoland1 RotterdamNetherlands1 BolognaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06866782 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.